Publikationen (wissenschaftliche Veröffentlichungen)

  • Dolak W, Beer A, Kristo I, Tribl B, Asari R, Schöniger-Hekele M, Wrba F, Schoppmann SF, Trauner M, Püspök A.  A retrospective study on the safety, diagnostic yield, and therapeutic effects of endoscopic unroofing for small gastric subepithelial tumors.Gastrointest Endosc. 2016 Apr 22. pii: S0016-5107(16)30065-7. doi: 10.1016/j.gie.2016.04.019. [Epub ahead of print] PMID: 27109457
  • Schiefer AI, Schoppmann SF, Birner P. Lymphovascular invasion of tumor cells in lymph node metastases has a negative impact on survival in esophageal cancer. Surgery. 2016 Aug;160(2):331-40. doi: 10.1016/j.surg.2016.02.034. Epub 2016 Apr 14. PMID: 27085684
  • Tamandl D, Ta J, Schmid R, Preusser M, Paireder M, Schoppmann SF, Haug A, Ba-Ssalamah A. Prognostic value of volumetric PET parameters in unresectable and metastatic esophageal cancer. Eur J Radiol. 2016 Mar;85(3):540-5. doi: 10.1016/j.ejrad.2016.01.002. Epub 2016 Jan 12. PMID: 26860665
  • Kristo I, Riegler M, Schoppmann SFShould antireflux surgery be considered after successful endoscopic treatment of Barrett’s esophagus with dysplasia and early cancer? Endoscopy. 2016 Jan;48(1):92. doi: 10.1055/s-0034-1393166. Epub 2015 Dec 28. PMID: 26710282
  • Drahos J, Schwameis K, Orzolek LD, Hao H, Birner P, Taylor PR, Pfeiffer RM, Schoppmann SF, Cook MB. MicroRNA Profiles of Barrett’s Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.Cancer Epidemiol Biomarkers Prev. 2016 Mar;25(3):429-37. doi: 10.1158/1055-9965.EPI-15-0161. Epub 2015 Nov 24. PMID: 26604271
  • Jomrich G, Schoppmann SF. Targeting HER 2 and angiogenesis in gastric cancer. Expert Rev Anticancer Ther. 2016;16(1):111-22. doi: 10.1586/14737140.2016.1121110. Epub 2015 Dec 5. Review. PMID: 26567753
  • Kristo I, Riegler M, Schoppmann SF. Laryngopharyngeal reflux COPD to uncover reflux and columnar lined esophagus. Int J Chron Obstruct Pulmon Dis. 2015 Sep 30;10:2095-6. doi: 10.2147/COPD.S93711. eCollection 2015. No abstract available. PMID: 26457051
  • Tamandl D, Paireder M, Asari R, Baltzer PA, Schoppmann SF, Ba-Ssalamah A.  Markers of sarcopenia quantified by computed tomography predict adverse long-term outcome in patients with resected oesophageal or gastro-oesophageal junction cancer.
  • Eur Radiol. 2016 May;26(5):1359-67. doi: 10.1007/s00330-015-3963-1. Epub 2015 Sep 3. PMID: 26334504
  • Dolak W, Mesteri I, Asari R, Preusser M, Tribl B, Wrba F, Schoppmann SF, Hejna M, Trauner M, Häfner M, Püspök A.  A pilot study of the endomicroscopic assessment of tumor extension in Barrett’s esophagus-associated neoplasia before endoscopic resection. Endosc Int Open. 2015 Feb;3(1):E19-28. doi: 10.1055/s-0034-1377935. Epub 2014 Oct 24. PMID: 26134766
  • Ilhan-Mutlu A, Starlinger P, Perkmann T, Schoppmann SF, Preusser M, Birner P.  Plasma fibrinogen and blood platelet counts are associated with response to neoadjuvant therapy in esophageal cancer.Biomark Med. 2015;9(6):617. doi: 10.2217/bmm.15.24. PMID: 26079965
  • Tamandl D, Gore RM, Fueger B, Kinsperger P, Hejna M, Paireder M, Haug A, Schoppmann SF, Ba-Ssalamah A. Change in volume parameters induced by neoadjuvant chemotherapy provide accurate prediction of overall survival after resection in patients with oesophageal cancer. Eur Radiol. 2016 Feb;26(2):311-21. doi: 10.1007/s00330-015-3860-7. Epub 2015 Jun
  • PMID: 26040648
  • Kristo I, Riegler M, Schoppmann SF. Int J Chron Obstruct Pulmon Dis. 2015 Sep 30;10:2095-6. doi: 10.2147/COPD.S93711. eCollection 2015. No abstract available.
  • Kristo I, Asari R, Rieder E, Riegler V, Schoppmann SF. Minerva Chir. 2015 Apr;70(2):107-18. Epub 2015 Feb 3. Review. PMID: 25645114
  • Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group. Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3. Epub 2015 May 31.
  • Ilhan-Mutlu A, Tezcan G, Schoppmann SF, Preusser M, Spyridoula K, Karanikas G, Birner P. microRNA-21 expression is elevated in esophageal adenocarcinoma after neoadjuvant chemotherapy.Cancer Invest. 2015 Jul;33(6):246-50.doi:10.3109/07357907.2015.1024319. Epub 2015 May 7. PMID: 25950983
  • Ilhan-Mutlu A, Starlinger P, Perkmann T, Schoppmann SF, Preusser M, Birner P.
  • Biomark Med. 2015;9(4):327-35. doi: 10.2217/bmm.14.111. Erratum in: Biomark Med. 2015;9(6):617. PMID: 25808437
  • Zacherl J, Roy-Shapira A, Bonavina L, Bapaye A, Kiesslich R, Schoppmann SF, Kessler WR, Selzer DJ, Broderick RC, Lehman GA, Horgan S. Endoscopic anterior fundoplication with the Medigus Ultrasonic Surgical Endostapler (MUSE™) for gastroesophageal reflux disease: 6-month results from a multi-center prospective trial. Surg Endosc. 2015 Jan;29(1):220-9. doi: 10.1007/s00464-014-3731-3. PMID: 25135443
  • Schwarz C, Soliman T, Györi G, Silberhumer G, Schoppmann SF, Mühlbacher F, Berlakovich GA. Abdominal drainage after liver transplantation from deceased donors. Langenbecks Arch Surg. 2015 Oct;400(7):813-9. doi: 10.1007/s00423-015-1338-3. Epub 2015 Sep 4. PMID: 26341224
  • Kristo I, Schoppmann SF Eur Surg 2015; 47(4):188-198 doi 10.1007/s10353-015-0329-5
  • Kristo I, Riegler FM, Asari R, Cosentini E, Schoppmann SF Eur Surg 2015 Epub ahead of print doi 10.1007/s10353-015-0340-x
  • Kandioler D, Schoppmann SF, Zwrtek R, Kappel S, Wolf B, Mittlböck M, Kührer I, Hejna M, Pluschnig U, Ba-Ssalamah A, Wrba F, Zacherl J The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group study.. J Thorac Cardiovasc Surg. 2014 Jul 22. pii: S0022-5223(14)00905-2. doi: 10.1016/j.jtcvs.2014.06.079. [Epub ahead of print] PMID: 25135238
  • Birner P, Berghoff AS, Dinhof C, Pirker C, Capper D, Schoppmann SF, Petzelbauer P, von Deimling A, Berger W, Preusser M. MAP kinase activity supported by BRAF (V600E) mutation rather than gene amplification is associated with ETV1 expression in melanoma brain metastases.Arch Dermatol Res. 2014 Jul 30. [Epub ahead of print] PMID: 25073704
  • Schoppmann SF, Ricken G, Ilhan-Mutlu A, Nirtl N, Streubel B, Preusser M, Birner P. Downregulation of CIC does not associate with overexpression of ETV1 or MAP kinase pathway activation in gastrointestinal stromal tumors.Cancer Invest. 2014 Aug;32(7):363-7. doi: 10.3109/07357907.2014.919304. Epub 2014 Jun 4. PMID: 24897389
  • Sahora K, Schindl M, Kuehrer I, Eisenhut A, Werba G, Brostjan C, Telek B, Ba’ssalamah A, Stift J, Schoppmann SF, Gnant M.  A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer. Anticancer Res. 2014 May;34(5):2377-84. PMID: 24778046
  • Schwameis K, Schwameis M, Zörner B, Lenglinger J, Asari R, Riegler FM, Schoppmann SF. Modern GERD treatment: feasibility of minimally invasive esophageal sphincter augmentation. Anticancer Res. 2014 May;34(5):2341-8. PMID: 24778041
  • Birner P, Pusch S, Christov C, Mihaylova S, Toumangelova-Uzeir K, Natchev S, Schoppmann SF, Tchorbanov A, Streubel B, Tuettenberg J, Guentchev M. Cancer. Mutant IDH1 inhibits PI3K/Akt signaling in human glioma. 2014 Aug 15;120(16):2440-7. doi: 10.1002/cncr.28732. Epub 2014 Apr 25. PMID: 24771584
  • Schwameis K, F, Stift J, Schoppmann S, Schwameis M, Stift A.  Small bowel adenocarcinoma – terra incognita: A demand for cross-national pooling of data. Oncol Lett   2014 May;7(5):1613-1617. Epub 2014 Feb 27. PMID: 24765188
  • Lenglinger J, Riegler MF, Schoppmann SF. Barrett’s esophagus and antireflux surgery: wraps, rings, and HALOs. Ann Surg. 2014 Apr 16. [Epub ahead of print] No abstract available.  PMID: 24743612
  • Riegler M, Asari R, Cosentini EP, Wrba F, Schoppmann SF. Critical assessment of a new endoscopic anatomic concept for the so-called cardia in the sense of the notions of Parmenides and Martin Heidegger]. Z Gastroenterol. 2014 Apr;52(4):367-73. doi: 10.1055/s-0034-1366188. Epub 2014 Apr 9. German. PMID: 24718942
  • Mesteri I, Schoppmann SF, Preusser M, Birner P. Eur J Cancer. 2014 May;50(7):1354-60. doi: 10.1016/j.ejca.2014.01.022. Epub 2014 Feb 21. PMID: 24565853
  • Hejna M, Birner P, Preusser M, Thallinger CM, Worel N, Asari R, Dolak W, Schmid R, Schoppmann SF, Raderer M.  Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tract.Mol Clin Oncol. 2013 Nov;1(6):1079-1083. Epub 2013 Sep 12. PMID: 24649296
  • Riegler M, Asari R, Schoppmann SF. Face Barrett’s: esophageal adenocarcinoma affects the young.J Gastrointest Surg. 2014 Apr;18(4):882-3. doi: 10.1007/s11605-013-2436-6. Epub 2013 Dec 24. No abstract available.  PMID: 24366369
  • Koperek O, Aumayr K, Schindl M, Werba G, Soleiman A, Schoppmann S, Sahora K, Birner P. Phosphorylation of STAT3 correlates with HER2 status, but not with survival in pancreatic ductal adenocarcinoma. APMIS. 2014 Jun;122(6):476-81. doi: 10.1111/apm.12194. Epub 2013 Oct 29. PMID: 24164699
  • Riegler M, Schwameis K, Asari R, Schoppmann SF. Otolaryngeal GERD symptoms and Barrett esophagus: implications for cancer prevention.J Clin Gastroenterol. 2014 Feb;48(2):191. doi: 10.1097/MCG.0b013e3182a49ff4. No abstract available.  PMID: 24045278
  • Mesteri I, Bayer G, Meyer J, Capper D, Schoppmann SF, von Deimling A, Birner P. Mod Pathol. 2014 Jan;27(1):135-44. doi: 10.1038/modpathol.2013.126. Epub 2013 Jul 26. PMID: 23887306
  • Aumayr K, Soleiman A, Sahora K, Schindl M, Werba G, Schoppmann SF, Birner P.Appl Immunohistochem Mol Morphol. 2014;22(2):146-52. doi: 10.1097/PAI.0b013e31828dc392. PMID: 23702645
  • Asari R, Riegler M, Schoppmann SF. Dilated distal esophagus: optimal position for magnetic sphincter augmentation.J Am Coll Surg. 2013 Dec;217(6):11556.doi:10.1016/j.jamcollsurg.2013.08.012. No abstract available. PMID: 24246629
  • Schwameis K, Fochtmann A, Schwameis M, Asari R, Schur S, Köstler W, Birner P, Ba-Ssalamah A, Zacherl J, Wrba F, Brodowicz T, Schoppmann SF. Surgical treatment of GIST–an institutional experience of a high-volume center. Int J Surg. 2013;11(9):801-6. doi: 10.1016/j.ijsu.2013.08.016. Epub 2013 Aug 30.
  • PMID: 23999064
  • Schoppmann SF, Langer FB, Prager G, Zacherl J. Outcome and complications of long-term self-expanding esophageal stenting. Dis Esophagus. 2013 Feb-Mar;26(2):154-8. doi: 10.1111/j.1442-2050.2012.01337.x. Epub 2012 Mar 12. PMID: 22409454
  • Panhofer P, Springer C, Izay B, Grasl M, Burian M, Schoppmann SF, Rath T, Jakesz R, Zacherl J. Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction Langenbecks Arch Surg. 2013 Feb;398(2):221-30. doi: 10.1007/s00423-012-0995-8. Epub 2012 Sep 2. PMID: 22941244
  • Preusser M, Capper D, Berghoff AS, Horvat R, Wrba F, Schindl M, Schoppmann SF, von Deimling A, Birner P. Expression of BRAF V600E mutant protein in epithelial ovarian tumors. Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):159-64. doi: 10.1097/PAI.0b013e31825d7402. PMID: 22820660
  • Schoppmann SF, Jesch B, Riegler MF, Maroske F, Schwameis K, Jomrich G, Birner P. Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus. Clin Exp Metastasis. 2013 Apr;30(4):441-6. doi: 10.1007/s10585-012-9549-2. Epub 2012 Nov 19. PMID: 23161183
  • Schoppmann SF, Jesch B, Zacherl J, Riegler MF, Friedrich J, Birner P. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer. Surgery. 2013 Apr;153(4):526-34. doi: 10.1016/j.surg.2012.10.007. Epub 2013 Jan 4. PMID: 23294880
  • Preusser M, Berghoff AS, Capper D, von Deimling A, Maroske F, Brodowicz T, Hejna M, Birner P, Schoppmann SF. No evidence for BRAF-V600E mutations in gastroeosophageal tumors: results from a high-throughput analysis of 534 cases using a mutation-specific antibody. Appl Immunohistochem Mol Morphol. 2013 Oct;21(5):426-30. doi: 10.1097/PAI.0b013e31827ce693. PMID: 23343956
  • Schoppmann SF, Asari R, Riegler M. Barrett’s esophagus as a marker for increased risk for esophageal cancer and cardiorespiratory disease. Endoscopy. 2013;45(2):152. doi: 10.1055/s-0032-1325964. Epub 2013 Jan 30. No abstract available.  PMID: 23364842
  • Schoppmann SF, Beer A, Nirtl N, Ba-Ssalamah A, Brodowicz T, Streubel B, Birner P. Downregulation of phosphatidylethanolamine binding protein 1 associates with clinical risk factors in gastrointestinal stromal tumors, but not with activation of the RAF-1-MEK-ETV1 pathway. Cancer Lett. 2013 Jul 10;335(1):26-30. doi: 10.1016/j.canlet.2013.01.044. Epub 2013 Jan 31. PMID: 23376254
  • Asari R, Riegler M, Schoppmann SF. Extending Barrett’s esophagus cancer risk profile towards genetic abnormalities. Mol Cytogenet. 2013 Mar 4;6(1):10. doi: 10.1186/1755-8166-6-10. No abstract available. PMID: 23452763
  • Preusser M, Berghoff AS, Ilhan-Mutlu A, Magerle M, Dinhof C, Widhalm G, Dieckmann K, Marosi C, Wöhrer A, Hackl M, Zöchbauer-Müller S, von Deimling A, Schoppmann SF, Zielinski CC, Streubel B, Birner P. ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer. Lung Cancer. 2013 Jun;80(3):278-83. doi: 10.1016/j.lungcan.2013.01.019. Epub 2013 Feb 27. PMID: 23453647
  • Pluschnig U, Schoppmann SF, Preusser M, Datler P, Asari R, Ba-Ssalamah A, Schwameis K, Birner P, Zacherl J, Hejna M. Modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for gastroesophageal adenocarcinoma Anticancer Res. 2013 Mar;33(3):1035-9. PMID:23482778
  • Preusser M, Berghoff AS, Ilhan-Mutlu A, Dinhof C, Magerle M, Marosi C, Hejna M, Capper D, VON Deimling A, Schoppmann SF, Birner P. Brain metastases of gastro-oesophageal cancer: evaluation of molecules with relevance for targeted therapies. Anticancer Res. 2013 Mar;33(3):1065-71. PMID:23482783
  • Schoppmann SF, Streubel B, Birner P. Amplification but not translocation of anaplastic lymphoma kinase is a frequent event in oesophageal cancer. Eur J Cancer. 2013 May;49(8):1876-81. doi: 10.1016/j.ejca.2013.02.005. Epub 2013 Mar 13. PMID: 23490651
  • Bareck E, Ba-Ssalamah A, Brodowicz T, Eisterer W, Häfner M, Högenauer C, Kastner U, Kühr T, Längle F, Liegl-Atzwanger B, Schoppmann SF, Widmann G.Wrba F, Zacherl J, Ploner F; Austrian representatives of Medical and Surgical Oncology, Pathology, Radiology, Nuclear Medicine, Gastroenterology, and Laboratory Medicine. Gastrointestinal stromal tumors: diagnosis, therapy and follow-up care in Austria. Wien Med Wochenschr. 2013 Mar;163(5-6):137-52. doi: 10.1007/s10354-013-0187-3. Epub 2013 Mar 19. PMID:23508516
  • Schwameis K, Ba-Ssalamah A, Wrba F, Birner P, Prager G, Hejna M, Schmid R, Asari R, Zacherl J, Schoppmann SF. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center Anticancer Res. 2013 May;33(5):2085-91. PMID:23645759
  • Schoppmann SF, Alidzanovic L, Schultheis A, Perkmann T, Brostjan C, Birner P. Thrombocytes Correlate with Lymphangiogenesis in Human Esophageal Cancer and Mediate Growth of Lymphatic Endothelial Cells In Vitro. PLoS One. 2013 Jun 26;8(6):e66941. Print 2013. PMID:23840559
  • Schoppmann S. Of asylum attendants and co-therapists [German]. Pflege Z. 2013 Jul;66(7):422-5. No abstract available. PMID:23866545
  • Ilhan-Mutlu A, Preusser M, Schoppmann SF, Asari R, Ba-Ssalamah A, Schwameis K, Pluschnig U, Birner P, Püspök A, Zacherl J, Hejna M. Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract. Anticancer Res. 2013 Aug;33(8):3455-9. PMID:23898119
  • Schoppmann SF, Vinatzer U, Popitsch N, Mittlböck M, Liebmann-Reindl S, Jomrich G, Streubel B, Birner P. Novel clinically relevant genes in gastrointestinal stromal tumors identified by exome sequencing. Clin Cancer Res. 2013 Oct 1;19(19):5329-39. doi: 10.1158/1078-0432.CCR-12-3863. Epub 2013 Aug 13. PMID:23942094
  • Schwameis K, Fochtmann A, Schwameis M, Asari R, Schur S, Köstler W, Birner P, Ba-Ssalamah A, Zacherl J, Wrba F, Brodowicz T, Schoppmann SF. Surgical treatment of GIST–an institutional experience of a high-volume center. Int J Surg. 2013;11(9):801-6. doi: 10.1016/j.ijsu.2013.08.016. Epub 2013 Aug 30. PMID:23999064
  • Lenglinger J, See SF, Beller L, Cosentini EP, Asari R, Wrba F, Riegler M, Schoppmann SF. Review on novel concepts of columnar lined esophagus. Wien Klin Wochenschr. 2013 Oct;125(19-20):577-90. doi: 10.1007/s00508-013-0418-z. Epub 2013 Sep 6. Review.PMID:24061694
  • Schindler A, Mozzanica F, Alfonsi E, Ginocchio D, Rieder E, Lenglinger J, Schoppmann SF, Scharitzer M, Pokieser P, Kuribayashi S, Kawamura O, Kusano M, Zelenik K. Upper esophageal sphincter dysfunction: diverticula-globus pharyngeus. Ann N Y Acad Sci. 2013 Oct;1300:250-60. doi: 10.1111/nyas.12251. Review.PMID:24117647
  • Asari R, Riegler M, Schoppmann SF. Dilated distal esophagus: optimal position for magnetic sphincter augmentation. J Am Coll Surg. 2013 Dec;217(6):1155-6. doi: 10.1016/j.jamcollsurg.2013.08.012. No abstract available. PMID:24246629
  • Hochgraeber I, Riesner C, Schoppmann S. The experience of people with dementia in a social care group: case study. Dementia (London). 2013 Nov;12(6):751-68. doi: 10.1177/1471301212444300. Epub 2012 Apr 19.PMID:24337638
  • Hejna M, Birner P, Preusser M, Thallinger CM, Worel N, Asari R, Dolak W, Schmid R, Schoppmann SF, Raderer M. Lack of correlation between blood group and HER-2 status in adenocarcinomas of the upper gastrointestinal tract. Mol Clin Oncol. 2013 Nov;1(6):1079-1083. Epub 2013 Sep 12. PMID:24649296
  • Lenglinger J, Riegler M, Cosentini E, Asari R, Mesteri I, Wrba F, Schoppmann SF. Review on the annual cancer risk of Barrett’s esophagus in persons with symptoms of gastroesophageal reflux disease. Anticancer Res. 2012 Dec;32(12):5465-73. Review. PMID: 23225453
  • Lenglinger J, See SF, Beller L, Cosentini E, Asari R, Wrba F, Riegler M, Schoppmann SF. The cardia: esophageal or gastric? Critical reviewing the anatomy and histopathology of the esophagogastric junction. Acta Chir Iugosl. 2012;59(3):15-26. Review. PMID: 23654002
  • Schoppmann SF, Jomrich G, Schwameis K, Streubl B, Birner P. Amplification but not translocation of ALK is a frequent event in esophageal cancer European Journal of Cancer in press Nov 2012
  • Schoppmann SF, Jesch B, Zacherl J, Riegler M, Friedrich J, Birner P. Lymphangiogenesis and lymphovascular invasion diminishes prognosis in esophageal cancer Surgery. 2012 Nov 20; PubMed PMID: 00396060
  • Lenglinger J, Riegler M, Cosentini E, Asari R, Mesteri I, Wrba F, Schoppmann SF. Review on the Annual Cancer Risk of Barretts Esophagus in Persons with Symptoms of Gastroesophageal Reflux Disease. Anticancer Research 32, PubMed PMID: 4738292383
  • Schoppmann SF, Jesch B, Riegler MF, Maroske F, Schwameis K, Jomrich G, Birner P. Podoplanin expressing cancer associated fibroblasts are associated with unfavourable prognosis in adenocarcinoma of the esophagus. Clin Exp Metastasis. 2012 Nov 19; PubMed PMID:23161183.
  • Pilat N, Schoppmann S, Stift J, Mazal P, Wekerle T, Berlakovich GA. No Evidence for Recipient-Derived Hepatocytes in Serial Biopsies of Sex-Mismatched Liver Transplants. Transplantation. 2012 Nov 15; 94 (9) :953-957. PubMed PMID:23034562.
  • Schoppmann SF, Riegler MF. Radial esophageal acid exposure and the dilated distal esophagus. J Gastroenterol. 2012 Nov; 47 (11) :1275-6. PubMed PMID:22763417.
  • Panhofer P, Springer C, Izay B, Grasl M, Burian M, Schoppmann SF, Rath T, Jakesz R, Zacherl J. Influence of resection extent on morbidity in surgery for squamous cell cancer at the pharyngoesophageal junction. Langenbecks Arch Surg. 2012 Sep 2; PubMed PMID:22941244.
  • Lenglinger J, Riegler M, Schoppmann S. Letter: cancer risk among persons with columnar-lined oesophagus. Aliment Pharmacol Ther. 2012 Sep; 36 (6) :599; author reply 600. PubMed PMID:22913846.
  • Schoppmann SF, Jesch B, Friedrich J, Jomrich G, Maroske F, Birner P. Phosphorylation of signal transducer and activator of transcription 3 (STAT3) correlates with Her-2 status, carbonic anhydrase 9 expression and prognosis in esophageal cancer. Clin Exp Metastasis. 2012 Aug; 29 (6) :615-24. PubMed PMID:22484976.
  • Birner P, Jesch B, Schultheis A, Schoppmann SF. RAF-kinase inhibitor protein (RKIP) downregulation in esophageal cancer and its metastases. Clin Exp Metastasis. 2012 Aug; 29 (6) :551-9. PubMed PMID:22460832.
  • Preusser M, Capper D, Berghoff AS, Horvat R, Wrba F, Schindl M, Schoppmann SF, von Deimling A, Birner P. Expression of BRAF V600E Mutant Protein in Epithelial Ovarian Tumors. Appl Immunohistochem Mol Morphol. 2012 Jul 19; PubMed PMID:22820660.
  • Schoppmann SF, Berghoff AS, Jesch B, Zacherl J, Nirtl N, Jomrich G, Maroske F, Streubel B, Mesteri I, Birner P. Expression of podoplanin is a rare event in sporadic gastrointestinal stromal tumors and does not influence prognosis. Future Oncol. 2012 Jul; 8 (7) :859-66. PubMed PMID:22830405.
  • Schoppmann SF, Berghoff A, Dinhof C, Jakesz R, Gnant M, Dubsky P, Jesch B, Heinzl H, Birner P. Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer. Breast Cancer Res Treat. 2012 Jul; 134 (1) :237-44. PubMed PMID:22350732.
  • Birner P, Schoppmann A, Schindl M, Dinhof C, Jesch B, Berghoff AS, Schoppmann SF. Human homologue for Caenorhabditis elegans CUL-4 protein overexpression is associated with malignant potential of epithelial ovarian tumours and poor outcome in carcinoma. J Clin Pathol. 2012 Jun; 65 (6) :507-11. PubMed PMID:22447918.
  • Maresch J, Schoppmann SF, Thallinger CM, Zielinski CC, Hejna M. Her-2/neu gene amplification and over-expression in stomach and esophageal adenocarcinoma: from pathology to treatment. Crit Rev Oncol Hematol. 2012 Jun; 82 (3) :310-22. PubMed PMID:21783379.
  • Birner P, Beer A, Vinatzer U, Stary S, Höftberger R, Nirtl N, Wrba F, Streubel B, Schoppmann SF. MAPKAP kinase 2 overexpression influences prognosis in gastrointestinal stromal tumors and associates with copy number variations on chromosome 1 and expression of p38 MAP kinase and ETV1. Clin Cancer Res. 2012 Apr 1; 18 (7) :1879-87. PubMed PMID:22351694.
  • Schoppmann SF, Langer FB, Prager G, Zacherl J. Outcome and complications of long-term self-expanding esophageal stenting. Dis Esophagus. 2012 Mar 12; PubMed PMID:22409454.
  • Lenglinger J, Riegler M, Schoppmann SF. Gastroesophageal reflux disease and metabolic syndrome. Intern Med. 2012; 51 (20) :2993. PubMed PMID:23064587.
  • Schoppmann A, Tamandl D, Herberger B, Längle F, Birner P, Geleff S, Grünberger T, Schoppmann SF. Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases. Anticancer Res. 2011 Dec; 31 (12) :4605-11. PubMed PMID:22199337.
  • Ba-Ssalamah A, Matzek W, Baroud S, Bastati N, Zacherl J, Schoppmann SF, Hejna M, Wrba F, Weber M, Herold CJ, Gore RM. Accuracy of hydro-multidetector row CT in the local T staging of oesophageal cancer compared to postoperative histopathological results. Eur Radiol. 2011 Nov; 21 (11) :2326-35. PubMed PMID:21710266.
  • Pertl L, Zacherl J, Mancusi G, Gächter JN, Asari R, Schoppmann S, Bigenzahn W, Schneider-Stickler B. High risk of unilateral recurrent laryngeal nerve paralysis after esophagectomy using cervical anastomosis. Eur Arch Otorhinolaryngol. 2011 Nov; 268 (11) :1605-10. PubMed PMID:21706158.
  • Birner P, Jesch B, Friedrich J, Riegler M, Zacherl J, Hejna M, Wrba F, Schultheis A, Schoppmann SF. Carbonic anhydrase IX overexpression is associated with diminished prognosis in esophageal cancer and correlates with Her-2 expression. Ann Surg Oncol. 2011 Nov; 18 (12) :3330-7. PubMed PMID:21519917.
  • Starlinger P, Brugger P, Reiter C, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia. 2011 Oct; 13 (10) :980-90. PubMed PMID:22028623; PubMed Central PMCID: PMC3201574.
  • Schoppmann SF, Jesch B, Zacherl J, Wrba F, Hejna M, Maresch J, Langer FB, Riegler MF, Pluschnig U, Birner P. HER-2 status in primary oesophageal cancer, lymph nodes and distant metastases. Br J Surg. 2011 Oct; 98 (10) :1408-13. PubMed PMID:21618213.
  • Bojic M, Pluschnig U, Zacherl J, Thallinger CM, Ba-Ssalamah A, Maresch J, Datler P, Schoppmann SF, Hejna M. Docetaxel, cisplatin and 5-fluorouracil plus granulocyte colony-stimulating factor prophylaxis in patients with metastatic adenocarcinoma of the stomach and gastroesophageal junction: experience at the Medical University of Vienna. Anticancer Res. 2011 Jun; 31 (6) :2379-82. PubMed PMID:21737668.
  • Starlinger P, Brugger P, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Myelosuppression of thrombocytes and monocytes is associated with a lack of synergy between chemotherapy and anti-VEGF treatment. Neoplasia. 2011 May; 13 (5) :419-27. PubMed PMID:21532882; PubMed Central PMCID: PMC3084618.
  • Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts. Dis Markers. 2011; 31 (2) :55-65. PubMed PMID:21896999.
  • Schoppmann SF, Jesch B, Friedrich J, Wrba F, Schultheis A, Pluschnig U, Maresch J, Zacherl J, Hejna M, Birner P. Expression of Her-2 in carcinomas of the esophagus. Am J Surg Pathol. 2010 Dec; 34 (12) :1868-73. PubMed PMID:21107094.
  • Schoppmann SF, Prager G, Langer FB, Riegler FM, Kabon B, Fleischmann E, Zacherl J. Open versus minimally invasive esophagectomy: a single-center case controlled study. Surg Endosc. 2010 Dec; 24 (12) :3044-53. PubMed PMID:20464423.
  • Starlinger P, Moll HP, Assinger A, Nemeth C, Hoetzenecker K, Gruenberger B, Gruenberger T, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C. Thrombospondin-1: a unique marker to identify in vitro platelet activation when monitoring in vivo processes. J Thromb Haemost. 2010 Aug; 8 (8) :1809-19. PubMed PMID:20492458.
  • Langer FB, Bohdjalian A, Shakeri-Leidenmühler S, Schoppmann SF, Zacherl J, Prager G. Conversion from sleeve gastrectomy to Roux-en-Y gastric bypass–indications and outcome. Obes Surg. 2010 Jul; 20 (7) :835-40. PubMed PMID:20393810.
  • Langer FB, Shakeri-Leidenmühler S, Bohdjalian A, Schoppmann S, Zacherl J, Felberbauer FX, Vila G, Prager G. Strategies for weight regain after sleeve gastrectomy. Surg Laparosc Endosc Percutan Tech. 2010 Jun; 20 (3) :159-61. PubMed PMID:20551813.
  • Schoppmann SF, Tamandl D, Roberts L, Jomrich G, Schoppmann A, Zwrtek R, Dubsky P, Gnant M, Jakesz R, Birner P. HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer. Ann Oncol. 2010 May; 21 (5) :955-60. PubMed PMID:19940005.
  • Langer FB, Schoppmann SF, Prager G, Riegler FM, Zacherl J. Solving the problem of difficult stent removal due to tissue ingrowth in partially uncovered esophageal self-expanding metal stents. Ann Thorac Surg. 2010 May; 89 (5) :1691-2. PubMed PMID:20417822.
  • Langer FB, Schoppmann SF, Prager G, Tomaselli F, Pluschnig U, Hejna M, Schmid R, Zacherl J. Temporary placement of self-expanding oesophageal stents as bridging for neo-adjuvant therapy. Ann Surg Oncol. 2010 Feb; 17 (2) :470-5. PubMed PMID:19859771.
  • Schoppmann SF, Prager G, Langer F, Riegler M, Fleischman E, Zacherl J. Fifty-five minimally invasive Esophagectomies: a single centre experience. Anticancer Res. 2009 Jul; 29 (7) :2719-25. PubMed PMID:19596952.
  • Silberhumer GR, Hufschmid M, Wrba F, Gyoeri G, Schoppmann S, Tribl B, Wenzl E, Prager G, Laengle F, Zacherl J. Surgery for gastrointestinal stromal tumors of the stomach. J Gastrointest Surg. 2009 Jul; 13 (7) :1213-9. PubMed PMID:19357931.
  • Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, Hüttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R, Austrian Breast and Colorectal Cancer Study Group. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?. Clin Breast Cancer. 2009 Jun; 9 Suppl 1:S18-27. PubMed PMID:19561003.
  • Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R, ABCSG-12 Trial Investigators, Marth C. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med. 2009 Feb 12; 360 (7) :679-91. PubMed PMID:19213681.
  • Blaha P, Exner R, Borgo AD, Bigenzahn S, Panhofer P, Riedl O, Schoppmann S, Bachleitner-Hofmann T, Sporn E, Pluschnig U, Fitzal F, Steger G, Jakesz R, Dubsky P, Gnant M. Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio. Breast Care (Basel). 2009; 4 (3) :155-161. PubMed PMID:21160541; PubMed Central PMCID: PMC2931002.
  • Silberhumer GR, Györi G, Burghuber C, Neumayer C, Riegler M, Jakesz R, Prager G, Schoppmann SF, Zacherl J. The value of protecting the longitudinal staple line with invaginating sutures during esophageal reconstruction by gastric tube pull-up. Dig Surg. 2009; 26 (4) :337-41. PubMed PMID:19729925.
  • Mlineritsch B, Tausch C, Singer C, Luschin-Ebengreuth G, Jakesz R, Ploner F, Stierer M, Melbinger E, Menzel C, Urbania A, Fridrik M, Steger G, Wohlmuth P, Gnant M, Greil R, Austrian Breast, Colorectal Cancer Study Group (ABCSG). Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17). Breast Cancer Res Treat. 2008 Nov; 112 (1) :203-13. PubMed PMID:18158620.
  • Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R, Austrian Breast and Colorectal Cancer Study Group (ABCSG). Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy. Lancet Oncol. 2008 Sep; 9 (9) :840-9. PubMed PMID:18718815.
  • Tamandl D, Herberger B, Gruenberger B, Schoppmann SF, Puhalla H, Schindl M, Schima W, Jakesz R, Gruenberger T. Adequate preoperative staging rarely leads to a change of intraoperative strategy in patients undergoing surgery for colorectal cancer liver metastases. Surgery. 2008 May; 143 (5) :648-57. PubMed PMID:18436013.
  • Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P. Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer. Anticancer Res. 2007 Mar-Apr; 27 (2) :949-52. PubMed PMID:17465225.
  • Tamandl D, Gruenberger B, Herberger B, Schoppmann S, Bodingbauer M, Schindl M, Puhalla H, Fleischmann E, Schima W, Jakesz R, Laengle F, Gruenberger T. Selective resection of colorectal liver metastases. Eur J Surg Oncol. 2007 Mar; 33 (2) :174-82. PubMed PMID:17046194.
  • Bachleitner-Hofmann T, Strohschneider M, Krieger P, Sachet M, Dubsky P, Hayden H, Schoppmann SF, Pfragner R, Gnant M, Friedl J, Stift A. Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma. J Clin Endocrinol Metab. 2006 Nov; 91 (11) :4571-7. PubMed PMID:16954161.
  • Schoppmann SF, Fenzl A, Schindl M, Bachleitner-Hofmann T, Nagy K, Gnant M, Horvat R, Jakesz R, Birner P. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Breast Cancer Res Treat. 2006 Sep; 99 (2) :135-41. PubMed PMID:16555123.
  • Schoppmann SF, Fenzl A, Nagy K, Unger S, Bayer G, Geleff S, Gnant M, Horvat R, Jakesz R, Birner P. VEGF-C expressing tumor-associated macrophages in lymph node positive breast cancer: impact on lymphangiogenesis and survival. Surgery. 2006 Jun; 139 (6) :839-46. PubMed PMID:16782443.
  • Schoppmann SF. Lymphangiogenesis, inflammation and metastasis. Anticancer Res. 2005 Nov-Dec; 25 (6C) :4503-11. PubMed PMID:16334134.
  • Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R, Austrian Breast and Colorectal Cancer Study Group. Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer. Ann Surg. 2004 Aug; 240 (2) :306-12. PubMed PMID:15273556; PubMed Central PMCID: PMC1356408.
  • Schoppmann SF, Soleiman A, Kalt R, Okubo Y, Benisch C, Nagavarapu U, Herron GS, Geleff S. Telomerase-immortalized lymphatic and blood vessel endothelial cells are functionally stable and retain their lineage specificity. Microcirculation. 2004 Apr-May; 11 (3) :261-9. PubMed PMID:15280080.
  • Valencak J, Heere-Ress E, Kopp T, Schoppmann SF, Kittler H, Pehamberger H. Selective immunohistochemical staining shows significant prognostic influence of lymphatic and blood vessels in patients with malignant melanoma. Eur J Cancer. 2004 Feb; 40 (3) :358-64. PubMed PMID:14746853.
  • Schoppmann SF, Schindl M, Bayer G, Aumayr K, Dienes J, Horvat R, Rudas M, Gnant M, Jakesz R, Birner P. Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer. Int J Cancer. 2003 May 10; 104 (6) :677-82. PubMed PMID:12640673.
  • Geleff S, Schoppmann SF, Oberhuber G. Increase in podoplanin-expressing intestinal lymphatic vessels in inflammatory bowel disease. Virchows Arch. 2003 Mar; 442 (3) :231-7. PubMed PMID:12647212.
  • Schindl M, Schoppmann SF, Ströbel T, Heinzl H, Leisser C, Horvat R, Birner P. Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors. Clin Cancer Res. 2003 Feb; 9 (2) :779-85. PubMed PMID:12576450.
  • Schoppmann SF, Birner P, Stöckl J, Kalt R, Ullrich R, Caucig C, Kriehuber E, Nagy K, Alitalo K, Kerjaschki D. Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis. Am J Pathol. 2002 Sep; 161 (3) :947-56. PubMed PMID:12213723; PubMed Central PMCID: PMC1867252.
  • Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G, Austrian Breast and Colorectal Cancer Study Group. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res. 2002 Jun; 8 (6) :1831-7. PubMed PMID:12060624.
  • Schoppmann SF, Horvat R, Birner P. Lymphatic vessels and lymphangiogenesis in female cancer: mechanisms, clinical impact and possible implications for anti-lymphangiogenic therapies (Review). Oncol Rep. 2002 May-Jun; 9 (3) :455-60. PubMed PMID:11956609.
  • Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, Stingl G, Kerjaschki D, Maurer D. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med. 2001 Sep 17; 194 (6) :797-808. PubMed PMID:11560995; PubMed Central PMCID: PMC2195953.
  • Schoppmann SF, Schindl M, Breiteneder-Geleff S, Soleima A, Breitenecker G, Karner B, Birner P. Inflammatory stromal reaction correlates with lymphatic microvessel density in early-stage cervival cancer. Anticancer Res. 2001 Sep-Oct; 21 (5) :3419-23. PubMed PMID:11848503.
  • Schindl M, Oberhuber G, Obermair A, Schoppmann SF, Karner B, Birner P. Overexpression of Id-1 protein is a marker for unfavorable prognosis in early-stage cervical cancer. Cancer Res. 2001 Aug 1; 61 (15) :5703-6. PubMed PMID:11479201.
  • Schoppmann SF, Birner P, Studer P, Breiteneder-Geleff S. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res. 2001 Jul-Aug; 21 (4A) :2351-5. PubMed PMID:11724292.

 


Top